Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome

NCT02343133 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematopoietic Syndrome Due to Acute Radiation Syndrome

Interventions

BIOLOGICAL: HemaMax
DRUG: Placebo

Sponsor

Neumedicines Inc.

Collaborators

[object Object]